Profile: Binax, Inc develops fundamentally new diagnostic tools that facilitate pathogen identification, thereby allowing targeted treatment for infectious diseases and promoting better patient management. Our NOW tests are rapid immunochromatographictests (ICT) that detect specific analytes in clinical specimens using our patented book-shaped device. We have FDA clearance for two urinary antigen tests, NOW streptococcus pneumoniae antigen test, for the detection of the most common cause of bacterial pneumonia & NOW legionella urinary antigen test.